These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7687517)
1. Characterization of a CD34+ cell line established from a child with large cell cutaneous lymphoma. Lorenzana AN; McCabe NR; Goodell WR; Zhang LQ; Miley D; Le Beau MM; Goldman S; Smith SD Cancer; 1993 Aug; 72(3):931-7. PubMed ID: 7687517 [TBL] [Abstract][Full Text] [Related]
2. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Matolcsy A; Chadburn A; Knowles DM Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611 [TBL] [Abstract][Full Text] [Related]
3. A translocation (8;14) in a cutaneous large B-cell lymphoma. Busschots AM; Geerts ML; Mecucci C; Stul M; Cassiman JJ; van den Berghe H Am J Clin Pathol; 1993 May; 99(5):615-21. PubMed ID: 8388165 [TBL] [Abstract][Full Text] [Related]
4. Establishment of Epstein-Barr virus-negative diffuse large cell lymphoma cell line with an 8;22 chromosomal translocation. Ichinose I; Nakano S; Ohshima K; Mitsugi K; Anzai K; Shida T; Niho Y Cancer Res; 1991 Oct; 51(19):5392-7. PubMed ID: 1913659 [TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features. Muniesa C; Pujol RM; Estrach MT; Gallardo F; García-Muret MP; Climent J; Salar A; Servitje O J Am Acad Dermatol; 2012 Apr; 66(4):650-4. PubMed ID: 21816504 [TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocytes isolated from a Ki-1-positive large cell lymphoma of the skin. Phenotypic characterization and analysis of cytokine secretion. Reinhold U; Abken H; Kukel S; Goeden B; Uerlich M; Neumann U; Kreysel HW Cancer; 1991 Nov; 68(10):2155-60. PubMed ID: 1655203 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line. Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862 [TBL] [Abstract][Full Text] [Related]
9. A human B-cell lymphoma line with a de novo multidrug resistance phenotype. Mohammad RM; Mohamed AN; KuKuruga M; Smith MR; al-Katib A Cancer; 1992 Mar; 69(6):1468-74. PubMed ID: 1540884 [TBL] [Abstract][Full Text] [Related]
11. Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas. Kaudewitz P; Burg G Semin Diagn Pathol; 1991 May; 8(2):117-24. PubMed ID: 1651550 [No Abstract] [Full Text] [Related]
12. Intravascular (angiotropic) large cell lymphoma: determination of monoclonality by polymerase chain reaction on paraffin-embedded tissues. Sleater JP; Segal GH; Scott MD; Masih AS Mod Pathol; 1994 Jun; 7(5):593-8. PubMed ID: 7524070 [TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases. Magro CM; Nash JW; Werling RW; Porcu P; Crowson N Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):7-11. PubMed ID: 16540723 [TBL] [Abstract][Full Text] [Related]
14. [T-cell/histiocyte-rich B-cell lymphoma: histology, immunophenotype and differential diagnosis]. Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Luo XL Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):771-5. PubMed ID: 16545182 [TBL] [Abstract][Full Text] [Related]
15. CD8+ cutaneous anaplastic large-cell lymphoma: report of two cases with immunophenotyping, T-cell-receptor gene rearrangement and electron microscopic studies. Kikuchi A; Sakuraoka K; Kurihara S; Akiyama M; Shimizu H; Nishikawa T Br J Dermatol; 1992 Apr; 126(4):404-8. PubMed ID: 1373950 [TBL] [Abstract][Full Text] [Related]
16. Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance. de Leval L; Harris NL Histopathology; 2003 Dec; 43(6):509-28. PubMed ID: 14636252 [TBL] [Abstract][Full Text] [Related]
17. Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: dimethyl sulfoxide inhibits IL-6-induced differentiation of SKW6-CL4 into IgM-secreting plasma cells. Teraoka H; Mikoshiba M; Takase K; Yamamoto K; Tsukada K Exp Cell Res; 1996 Jan; 222(1):218-24. PubMed ID: 8549666 [TBL] [Abstract][Full Text] [Related]
18. Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells. Rowan W; Tite J; Topley P; Brett SJ Immunology; 1998 Nov; 95(3):427-36. PubMed ID: 9824507 [TBL] [Abstract][Full Text] [Related]
19. Growth regulation of a human mature B cell line, B104, by anti-IgM and anti-IgD antibodies. Kim KM; Yoshimura T; Watanabe H; Ishigami T; Nambu M; Hata D; Higaki Y; Sasaki M; Tsutsui T; Mayumi M J Immunol; 1991 Feb; 146(3):819-25. PubMed ID: 1988498 [TBL] [Abstract][Full Text] [Related]
20. A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma. Amini RM; Berglund M; Rosenquist R; Von Heideman A; Lagercrantz S; Thunberg U; Bergh J; Sundström C; Glimelius B; Enblad G Leuk Lymphoma; 2002 Nov; 43(11):2179-89. PubMed ID: 12533045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]